BUROW KRISTINA purchased 46.4% of their position (1.92M shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/29/2025ACC: 0001012975-25-000681
Director10% Owner
Since Sep 2023
+1.92M
Net shares
Net buyer
$5.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.92M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.92M
Price / share
$2.61
Trade value
$5M
% of position
46.4%
10/27/2025
4.13M→6.05M
Total
Net shares
+1.92M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/27/2025 | P · Purchase | +1.92M | $2.61 | $5M | 46.4% | 4.13M | 6.05M |
| Total | +1.92M | $5M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)5
Common Stock
IndirectShares owned12.21M
Common Stock
IndirectShares owned11.89M
Common Stock
IndirectShares owned2.32M
Common Stock
DirectShares owned47.72K
Common Stock
IndirectShares owned1.39M
Total
47.72K direct·27.80M indirect27.85M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.21M | Indirect |
| Common Stock | 11.89M | Indirect |
| Common Stock | 2.32M | Indirect |
| Common Stock | 47.72K | Direct |
| Common Stock | 1.39M | Indirect |
| Total | 27.85M | 47.72K direct·27.80M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported